JOONGANG DNM Co.Ltd (051980) - Net Assets
Based on the latest financial reports, JOONGANG DNM Co.Ltd (051980) has net assets worth ₩98.99 Billion KRW (≈ $67.08 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩121.79 Billion ≈ $82.54 Million USD) and total liabilities (₩22.80 Billion ≈ $15.45 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check JOONGANG DNM Co.Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩98.99 Billion |
| % of Total Assets | 81.28% |
| Annual Growth Rate | 7.42% |
| 5-Year Change | 287.56% |
| 10-Year Change | 799.66% |
| Growth Volatility | 63.12 |
JOONGANG DNM Co.Ltd - Net Assets Trend (2011–2024)
This chart illustrates how JOONGANG DNM Co.Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is JOONGANG DNM Co.Ltd worth.
Annual Net Assets for JOONGANG DNM Co.Ltd (2011–2024)
The table below shows the annual net assets of JOONGANG DNM Co.Ltd from 2011 to 2024. Also explore 051980 net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩96.67 Billion ≈ $65.51 Million |
+52.27% |
| 2023-12-31 | ₩63.49 Billion ≈ $43.02 Million |
+200.75% |
| 2022-12-31 | ₩21.11 Billion ≈ $14.31 Million |
-42.56% |
| 2021-12-31 | ₩36.75 Billion ≈ $24.91 Million |
+47.35% |
| 2020-12-31 | ₩24.94 Billion ≈ $16.90 Million |
+1.99% |
| 2019-12-31 | ₩24.46 Billion ≈ $16.57 Million |
+73.32% |
| 2018-12-31 | ₩14.11 Billion ≈ $9.56 Million |
+8.70% |
| 2017-12-31 | ₩12.98 Billion ≈ $8.80 Million |
+5.20% |
| 2016-12-31 | ₩12.34 Billion ≈ $8.36 Million |
+14.83% |
| 2015-12-31 | ₩10.75 Billion ≈ $7.28 Million |
-66.16% |
| 2014-12-31 | ₩31.75 Billion ≈ $21.52 Million |
-24.64% |
| 2013-12-31 | ₩42.13 Billion ≈ $28.55 Million |
-0.69% |
| 2012-12-31 | ₩42.43 Billion ≈ $28.75 Million |
+11.28% |
| 2011-12-31 | ₩38.13 Billion ≈ $25.84 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to JOONGANG DNM Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 19243501953000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩289.10 Billion | 299.07% |
| Total Equity | ₩96.67 Billion | 100.00% |
JOONGANG DNM Co.Ltd Competitors by Market Cap
The table below lists competitors of JOONGANG DNM Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kron Telekomunikasyon Hizmetleri AS
IS:KRONT
|
$77.77 Million |
|
PT Ingria Pratama Capitalindo Tbk
JK:GRIA
|
$77.79 Million |
|
WINS Co. Ltd
KQ:136540
|
$77.83 Million |
|
Innoviz Technologies
NASDAQ:INVZ
|
$77.86 Million |
|
Mirae Asset Daewoo Special Purpose Acquisition Company 4 Co. Ltd
KQ:333430
|
$77.76 Million |
|
Amata VN PCL
BK:AMATAV
|
$77.74 Million |
|
PolyPid
NASDAQ:PYPD
|
$77.73 Million |
|
Nasmed Ozel Saglik Hizmetleri Ticaret AS
IS:EGEPO
|
$77.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JOONGANG DNM Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 63,485,739,990 to 96,668,561,790, a change of 33,182,821,800 (52.3%).
- Net loss of 76,828,193,470 reduced equity.
- Other factors increased equity by 110,011,015,270.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-76.83 Billion | -79.48% |
| Other Changes | ₩110.01 Billion | +113.8% |
| Total Change | ₩- | 52.27% |
Book Value vs Market Value Analysis
This analysis compares JOONGANG DNM Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.08x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.55x to 1.08x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1866.94 | ₩1035.00 | x |
| 2017-12-31 | ₩1973.05 | ₩1035.00 | x |
| 2018-12-31 | ₩1767.05 | ₩1035.00 | x |
| 2019-12-31 | ₩1610.56 | ₩1035.00 | x |
| 2020-12-31 | ₩1265.40 | ₩1035.00 | x |
| 2021-12-31 | ₩1066.99 | ₩1035.00 | x |
| 2022-12-31 | ₩579.30 | ₩1035.00 | x |
| 2023-12-31 | ₩811.05 | ₩1035.00 | x |
| 2024-12-31 | ₩961.93 | ₩1035.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JOONGANG DNM Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -79.48%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -411.03%
- • Asset Turnover: 0.15x
- • Equity Multiplier: 1.29x
- Recent ROE (-79.48%) is below the historical average (-48.15%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 7.72% | 9.18% | 0.55x | 1.54x | ₩-1.05 Billion |
| 2012 | 6.43% | 7.15% | 0.72x | 1.24x | ₩-1.80 Billion |
| 2013 | -37.45% | -50.59% | 0.47x | 1.56x | ₩-18.54 Billion |
| 2014 | -28.19% | -40.92% | 0.52x | 1.33x | ₩-11.37 Billion |
| 2015 | -205.20% | -108.88% | 0.65x | 2.88x | ₩-21.51 Billion |
| 2016 | -30.38% | -19.96% | 0.92x | 1.65x | ₩-4.74 Billion |
| 2017 | 2.53% | 4.59% | 0.30x | 1.87x | ₩-969.32 Million |
| 2018 | -19.38% | -24.34% | 0.51x | 1.58x | ₩-4.15 Billion |
| 2019 | -32.51% | -81.29% | 0.28x | 1.43x | ₩-10.40 Billion |
| 2020 | -48.53% | -112.54% | 0.19x | 2.23x | ₩-14.60 Billion |
| 2021 | -46.84% | -132.10% | 0.25x | 1.41x | ₩-20.89 Billion |
| 2022 | -86.57% | -62.90% | 0.83x | 1.65x | ₩-20.39 Billion |
| 2023 | -76.28% | -184.15% | 0.20x | 2.06x | ₩-54.77 Billion |
| 2024 | -79.48% | -411.03% | 0.15x | 1.29x | ₩-86.50 Billion |
Industry Comparison
This section compares JOONGANG DNM Co.Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $92,874,480,407
- Average return on equity (ROE) among peers: -14.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JOONGANG DNM Co.Ltd (051980) | ₩98.99 Billion | 7.72% | 0.23x | $77.76 Million |
| NSN Co. Ltd (031860) | $51.00 Billion | -27.70% | 0.20x | $12.68 Million |
| GeneMatrix Inc (109820) | $11.89 Billion | -9.45% | 0.43x | $21.47 Million |
| Genoray Co. Ltd (122310) | $78.82 Billion | 18.17% | 0.26x | $27.41 Million |
| Green Cross Lab Cell Corporation (144510) | $457.79 Billion | -16.14% | 0.26x | $143.08 Million |
| Optipharm.CO.LTD (153710) | $12.79 Billion | -12.25% | 0.55x | $45.48 Million |
| Cancer Rop Co. Ltd. (180400) | $95.76 Billion | -30.32% | 0.62x | $159.09 Million |
| Cytogen Inc (217330) | $35.99 Billion | -34.29% | 0.73x | $47.29 Million |
| Gencurix Inc (229000) | $14.90 Billion | -24.34% | 1.02x | $31.07 Million |
| P&K Skin Research Center Co. Ltd (347740) | $76.94 Billion | 7.56% | 0.07x | $33.39 Million |
About JOONGANG DNM Co.Ltd
JOONGANG ADVANCED MATERIALS Co., Ltd. manufactures and sells communication equipment and video information display devices in South Korea and internationally. The company engages in manufacture of PVC products and building materials chassis, door frames, ducts; distribution agency business; secondary battery materials business; window construction, electronic commerce, and mail order sales; whole… Read more